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Abstract
Clearance of apoptotic cells by engulfment plays an important role in the homeostasis and development of multicellular
organisms. Despite the fact that the recognition of apoptotic cells by engulfment receptors is critical in inducing the
engulfment process, the molecular mechanisms are still poorly understood. Here, we characterize a novel cell corpse
engulfment pathway mediated by the integrin a subunit PAT-2 in Caenorhabditis elegans and show that it specifically
functions in muscle-mediated engulfment during embryogenesis. Inactivation of pat-2 results in a defect in apoptotic cell
internalization. The PAT-2 extracellular region binds to the surface of apoptotic cells in vivo, and the intracellular region may
mediate signaling for engulfment. We identify essential roles of small GTPase CDC-42 and its activator UIG-1, a guanine-
nucleotide exchange factor, in PAT-2–mediated cell corpse removal. PAT-2 and CDC-42 both function in muscle cells for
apoptotic cell removal and are co-localized in growing muscle pseudopods around apoptotic cells. Our data suggest that
PAT-2 functions through UIG-1 for CDC-42 activation, which in turn leads to cytoskeletal rearrangement and apoptotic cell
internalization by muscle cells. Moreover, in contrast to PAT-2, the other integrin a subunit INA-1 and the engulfment
receptor CED-1, which signal through the conserved signaling molecules CED-5 (DOCK180)/CED-12 (ELMO) or CED-6 (GULP)
respectively, preferentially act in epithelial cells to mediate cell corpse removal during mid-embryogenesis. Our results show
that different engulfing cells utilize distinct repertoires of receptors for engulfment at the whole organism level.
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Introduction
During the development of multicellular organisms, cells that
are unnecessary, damaged, or harmful undergo programmed cell
death (apoptosis) [1]. Apoptotic cells are recognized and subse-
quently internalized by engulfing cells [2,3]. Improper engulfment
of apoptotic cells has been linked to diseases: too little engulfment
may cause inflammation, autoimmune diseases, and cancers [4–6],
whereas too much engulfment has been implicated in degenerative
diseases [7–9].
In flies and mammals, engulfment of apoptotic cells is mediated
by ‘‘professional’’ phagocytes, such as mobile macrophages and
dendritic cells, or by ‘‘amateur’’ phagocytes, such as muscle cells,
epithelial cells, and endothelial cells [10–14]. Several mammalian
receptors involved in apoptotic cell engulfment have been
identified and characterized. Receptors such as BAI1 [15],
stabilin-1 [16], stabilin-2 [17], TIM-1 [18], TIM-3 [19], TIM-4
[18], integrins [20,21], and receptor tyrosine kinase Mer [22] bind
to the ‘‘eat me’’ signal, externalized phosphatidylserine (PS)
[23,24], on the surface of apoptotic cells either directly [25,26] or
through bridging molecules [27,28]. BAI1, integrins, and Mer
then signal through the conserved DOCK180/ELMO1/RAC
GTPase signaling module to promote the internalization of
apoptotic cells [15,29–31], whereas stabilin-1 and stabilin-2 do
so through the intracellular adaptor GULP [16]. Other ‘‘eat me’’
signal and receptor pairs for engulfment have been reported. For
example, lectin receptors bind to altered sugars on apoptotic cells
[32], scavenger receptors to oxidized LDL-like moieties [33], and
CD14 to ICAM3 [34]. The in vivo role of most of these receptors in
the clearance of apoptotic cells and the tissues in which they act at
the whole organism level have not been defined.
During the development of a C. elegans adult hermaphrodite,
1090 somatic cells are generated, 131 of which undergo apoptosis
[35–37]. The apoptotic cells are removed by their neighboring
cells [35,38]. Cell types such as hypodermal cells (which constitute
the external epithelium), pharyngeal muscle cells, and intestinal
cells have been shown to function as engulfing cells [37,38]. Three
partially redundant pathways that regulate the engulfment process
have been identified. The first pathway is mediated by two cell-
surface proteins CED-1 (mammalian homologue MEGF10) and
CED-7 (ABCA1) [39,40]. CED-1 binds to an apoptotic cell
through secreted molecule TTR-52 (transthyretin) and transduces
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and DYN-1 (dynamin) to promote the engulfment and degradation
of apoptotic cells [41–43]. The second pathway is regulated by at
least three engulfment receptors, phosphatidylserine receptor PSR-
1 [44], Frizzled MOM-5 [45], and integrin INA-1/PAT-3 [46], all
of which signal through the adaptor protein CED-2 (CRKII) and
the bipartite GEF complex CED-5 (DOCK180)/CED-12 (ELMO)
for CED-10 (RAC1) GTPase activation [47–52]. Phosphoinositide
phosphatase MTM-1 (myotubularin) negatively regulates this
pathway by inhibiting the recruitment of CED-12 to the plasma
membrane [53,54]. These two engulfment pathways may converge
at CED-10 GTPase, which promotes the actin-based cytoskeleton
rearrangement required for phagocytosis of apoptotic cells in
engulfing cells [55]. CED-10 activity is negatively regulated by
GTPase activating protein SRGP-1 during the engulfment process
[56]. Compared to these two major pathways, little is known about
the third pathway, which is negatively regulated by the cytoskeletal
regulator ABL-1 (Abl), which inhibits the engulfment of apoptotic
cells by inhibiting ABI-1 (Abl-interacting protein) and acts
independently of CED-10 [57].
Integrins are transmembrane ab heterodimers that make
connections to the extracellular matrix and cytoskeleton and
activate several signaling pathways required for multiple cellular
processes, including cell adhesion, cell migration, and cell survival
[58,59]. C. elegans has two integrin a subunits, INA-1 and PAT-2,
and a single b subunit, PAT-3 [60–62]. Integrin PAT-2/PAT-3 is
a component of muscle attachment complexes and is essential for
sarcomere assembly [63,65] and also acts to direct muscle arm
extension [66] and distal tip cell migration [67]. We have recently
shown that integrin INA-1/PAT-3 functions as an engulfment
receptor for apoptotic cells [46]. Intriguingly, the pat-3 knockout
mutant has a stronger defect in cell corpse engulfment than the
ina-1 mutant [46], raising the possibility that pat-2 may also
mediate the removal of apoptotic cells. In this study, we examined
and characterized the role of pat-2 in cell corpse engulfment and
showed that it functions in the muscle-mediated internalization of
apoptotic cells and acts through a pathway distinct from the
previously known pathways.
Results
pat-2 loss-of-function results in an increased number of
embryonic cell corpses
pat-2(st567) mutants [64] and worms treated with pat-2 RNAi
are embryonic lethal and show a phenotype of paralyzed arrest at
the two-fold stage (Pat), as PAT-2 plays an essential role in body
wall muscle assembly and function during embryogenesis [63–65].
We tested the involvement of pat-2 in apoptosis by counting the
number of apoptotic cells at the comma and 1.5-fold stages, the
two stages at which the majority of embryonic apoptosis occurs
[37] and pat-2 mutant embryos are still developing normally, and
found that both pat-2(st567) and pat-2(RNAi) embryos had a Ced
(cell death abnormal) phenotype with increased numbers of
apoptotic cells (Table 1). The Ced phenotype of the pat-2(st567)
mutant was rescued by the transgene Ppat-2pat-2::gfp, in which the
pat-2::gfp translational fusion construct is expressed under the
control of the endogenous pat-2 promoter Ppat-2 (Table 2),
confirming that the Ced phenotype of the pat-2(st567) mutant
was specifically caused by pat-2 loss of function. The Ppat-2pat-2::gfp
transgene also rescued the Pat phenotype of the pat-2(st567)
mutant (Table 3).
Author Summary
When cells undergo apoptosis, their corpses are quickly
recognized and phagocytosed by engulfing cells. Although
many cell types, such as muscle cells and epithelial cells,
possess the ability to remove apoptotic cells, little is
known about the receptors and signaling pathways used
for apoptotic cell uptake by these ‘‘amateur’’ phagocytes.
We show that, in Caenorhabditis elegans, integrin PAT-2/
PAT-3 functions as an engulfment receptor in muscle cells.
The integrin a subunit PAT-2 mediates both the recogni-
tion and subsequent phagocytosis of apoptotic cells. PAT-
2 signals through UIG-1 for CDC-42 activation, leading to
the cytoskeletal reorganization as the engulfing muscle
cell extends pseudopods around the apoptotic cell.
Furthermore, in contrast to PAT-2, the other integrin a
subunit INA-1 and the engulfment receptor CED-1, both of
which appear to act upstream of small GTPase CED-10
(RAC1), predominantly function in epithelial cells to
mediate cell corpse removal. Therefore, epithelial cells
and muscle cells employ different engulfment receptors
for apoptotic cell recognition, downstream signaling, and
specific GTPase activation during apoptotic cell removal.
Table 1. pat-2 mutants contain more apoptotic cells during
mid-embryogenesis than the wild-type.
Genotype No. of cell corpses
a
Comma 1.5-fold Pat
b
wild-type 9.061.1 9.961.3 nonPat
pat-2(RNAi) 12.961.7
** 13.261.6
** Pat
pat-2(st567)
c 13.661.6
** 13.661.5
** Pat
pat-2(st567)
d 13.361.2
** 13.461.7
** Pat
pat-2(st567)
d treated with pat-2 RNAi 13.061.7
** 13.561.2
** Pat
ced-3(n717) 0.160.3 0.060.0 nonPat
pat-2(st567); ced-3(n717)
e 0.060.0 0.160.2 Pat
ced-4(n1162) 0.160.3 0.060.0 nonPat
ced-4(n1162); pat-2(RNAi) 0.160.3 0.260.4 Pat
ina-1(RNAi) 11.161.8
** 11.761.4
** nonPat
pat-2(st567)
d; ina-1(RNAi) 14.361.5
# 15.961.7
## Pat
pat-3(RNAi) 14.562.0
** 15.762.0
** Pat
pat-3(st564)
f 15.061.2
** 14.861.2
** Pat
pat-2(st567)
d; pat-3(RNAi) 14.261.7 15.461.9 Pat
aThe number of cell corpses in each genotype was scored at the indicated
embryonic stage.
bEmbryos that showed normal embryogenesis were scored as nonPat and
those paralyzed at the 2-fold stage were scored as Pat.
cHomozygous progeny of unc-79(e1068) pat-2(st567)/dpy-17(e164) heterozygous
mothers.
dNon-transgenic progeny of unc-79(e1068) pat-2(st567); Ex[Ppat-2pat-2::gfp]
mothers.
eNon-transgenic progeny of unc-79(e1068) pat-2(st567); ced-3(n717); Ex[Ppat-2pat-
2::gfp] mothers.
fHomozygous progeny of pat-3(st564)/qC1 dpy-19(e1259) glp-1(q339)
heterozygous mothers. pat-2, ina-1,a n dpat-3 single mutants were compared to
the wild-type (
**p,0.001) and double mutants were compared to the
corresponding single mutants (
#p,0.05 and
##p,0.001) at each stage. All
comparisons were performed using the unpaired t test. The cell corpse
numbers of homozygous pat-2(st567)
d embryos treated with pat-2 RNAi are not
distinguishable from those of pat-2(st567)
d or pat-2(RNAi) embryos at the same
stage. Data are presented as the mean 6 standard deviation (SD) for .15
embryos per stage.
doi:10.1371/journal.pgen.1002663.t001
PAT-2/PAT-3 Engulfment Receptor for Cell Corpses
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apoptotic genes ced-3 and ced-4 that block almost all programmed
cell death [68], suppressed the phenotype of an increased number
of cell corpses in pat-2(st567) or pat-2(RNAi) embryos (Table 1),
showing that the extra cell corpses observed in the pat-2 mutants
were generated by programmed cell death. In contrast, the Pat
phenotype of the pat-2(st567) or pat-2(RNAi) mutants was not
suppressed by either the ced-3 or ced-4 mutation (Table 1). The fact
that the Pat and Ced phenotypes can be uncoupled shows they are
probably due to the loss of different pat-2 functions.
pat-2 is required for the removal of embryonic cell
corpses
To determine the cause of the Ced phenotype of the pat-2
mutant, we performed a time-lapse differential interference
contrast (DIC) microscopy analysis of cell corpses in the wild-
type and pat-2(st567) mutant during embryogenesis prior to the 2-
fold stage. We found that, although the timing and number of cell
death events were similar in the two types of embryo (Figure 1A),
the length of time that the cell corpses persisted was significantly
different (Figure 1B). In the wild-type, approximately 97% of cell
corpses disappeared within 40 minutes and no cell corpses
persisted longer than 60 minutes, whereas, in the pat-2 embryo,
more than 50% of the cell corpses persisted longer than
40 minutes and about 25% longer than 100 minutes. These
results demonstrate that pat-2 functions in the clearance of cell
corpses.
pat-2 does not function in any previously known
pathway for apoptotic cell removal
In addition to PAT-2, C. elegans has another integrin a subunit,
INA-1, which forms a complex with the single integrin b subunit,
PAT-3, on the cell surface [62] and is also required for the
clearance of embryonic cell corpses [46]. RNAi inactivation of
either ina-1 or pat-3 results in increased numbers of apoptotic cells
at the comma and 1.5-fold stages [46] (Table 1). The pat-2(st567)
mutation further increased the number of cell corpses in the ina-
1(RNAi) mutant, but not in the pat-3 mutant (Table 1). These
results support the notions that PAT-2, like INA-1, acts together
with PAT-3 during cell corpse clearance and that the two
integrins, PAT-2/PAT-3 and INA-1/PAT-3, function in a
partially redundant fashion during the clearance process.
We next determined whether pat-2 functioned together with
previously identified genes to promote cell corpse removal. The
two major pathways that regulate cell corpse removal are
mediated, respectively, by ced-1, ced-6, and ced-7 or ced-2, ced-5,
and ced-12 [2]. We therefore generated and analyzed double
mutants containing either the pat-2(st567) or pat-2(RNAi) mutation
and strong loss-of-function or null alleles of the engulfment ced
genes for the two pathways. Interestingly, the pat-2(st567) or pat-
2(RNAi) mutation further enhanced the engulfment defect in
mutants defective in either pathway (Table 4). This suggests two
possibilities. First, pat-2 could act in both pathways, with the
combination of a pat-2 mutation and a defect in either pathway
Table 2. pat-2 acts in muscle cells to mediate apoptotic cell
engulfment.
Genotype Transgene No. of cell corpses
a
Comma 1.5-fold
Wild-type - 9.061.1 9.961.3
Wild-type Ppat-2pat-2::gfp 9.361.5 10.561.4
pat-2(st567)
b - 13.361.2 13.461.7
pat-2(st567)
c - 13.561.1 13.461.3
pat-2(st567) Ppat-2pat-2::gfp 9.461.2
## 10.061.5
##
pat-2(st567) Punc-54pat-2::gfp 9.261.3
## 10.261.5
##
pat-2(st567)
b Pajm-1pat-2::gfp 12.761.6
** 13.161.7
**
pat-2(st567)
c Punc-54ced-1::gfp 13.260.9
** 13.661.0
**
pat-2(st567)
d Punc-54ina-1::gfp 11.561.0
##** 11.861.2
##**
ina-1(gm144) - 12.261.6 12.561.9
ina-1(gm144) Punc-54ina-1::gfp 13.160.8
** 13.760.9
**
ina-1(gm144) Pajm-1ina-1::gfp 10.260.6
## 10.560.7
##
ina-1(gm144) Pajm-1pat-2::gfp 11.460.5
e #** 11.660.5
e #**
ced-1(e1735) - 19.161.7 24.161.4
ced-1(e1735) Pced-1ced-1::gfp 9.461.3
## 9.261.0
##
ced-1(e1735) Punc-54ced-1::gfp 18.261.9
** 24.162.3
**
ced-1(e1735) Pajm-1ced-1::gfp 9.662.0
## 10.562.2
##
ced-1(e1735) Pajm-1pat-2::gfp 19.561.0
** 23.860.9
**
aThe number of cell corpses in each genotype was scored at the indicated
embryonic stage.
bHomozygous progeny of unc-79(e1068) pat-2(st567); Ex[Ppat-2pat-2::gfp]
mothers.
cHomozygous progeny of unc-79(e1068) pat-2(st567); Ex[Ppat-2pat-2::mcherry]
mothers.
dHomozygous progeny of unc-79(e1068) pat-2(st567)/dpy-17(e164)
heterozygous mothers.
eThe number of cell corpses was scored in the F1 transgenic progeny of the
injected worms, n=10 at each stage. Transgenic embryos were generated and
heat-shocked as described in Materials and Methods. Mutants carrying the
transgene were compared to the wild-type (*p,0.05 and **p,0.001) or to
mutants without the transgene (
#p,0.05 and
## p,0.001) at each stage. Wild-
type carrying the transgene were compared to the wild-type (*p,0.05 and
**p,0.001). All comparisons were performed using the unpaired t test. Data are
presented as the mean 6 standard deviation (SD) for .20 (unless noted above)
embryos at each stage.
doi:10.1371/journal.pgen.1002663.t002
Table 3. Effects of mutant pat-2 transgenes on the Ced and
Pat phenotypes.
Genotype Transgene No. of cell corpses
a
Comma 1.5-fold Pat
b
Wild-type - 9.061.1 9.961.3 nonPat
Wild-type Ppat-2pat-2Dcyto::gfp 11.661.8
** 13.261.6
** nonPat
Wild-type/ heat
shock
Phsppat-2(ex):mcherry 10.061.5
* 13.361.4
** nonPat
Wild-type Punc-54pat-2(ex):mcherry 11.361.2
* 12.461.0
** nonPat
pat-2(st567)
c - 13.461.2 13.461.7 Pat
pat-2(st567) Ppat-2pat-2::gfp 9.461.2
## 10.061.5
## nonPat
pat-2(st567) Ppat-2pat-2Dcyto::gfp 13.061.4
** 13.761.7
** nonPat
aThe number of cell corpses in each genotype was scored at the indicated
embryonic stage.
bEmbryos that showed normal embryogenesis were scored as nonPat, and
those paralyzed at the 2-fold stage were scored as Pat.
cNon-transgenic progeny of unc-79(e1068) pat-2(st567); Ex[Ppat-2pat-2::gfp]
mothers. Transgenic embryos were generated and heat-shocked as described in
Materials and Methods. Mutants carrying the transgene were compared to the
wild-type (*p,0.05 and **p,0.001) or to mutants without the transgene
(
#p,0.05 and
## p,0.001) at each stage. Wild-type carrying the transgene
were compared to the wild-type (*p,0.05 and **p,0.001). All comparisons
were performed using the unpaired t test. Data are presented as the mean 6
standard deviation (SD) for .20 embryos at each stage.
doi:10.1371/journal.pgen.1002663.t003
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separate pathway that is partially redundant with these two
pathways. To distinguish between these two possibilities, we tested
whether the pat-2(st567) or pat-2(RNAi) mutation could increase
the engulfment defect in double mutants between the two
pathways, such as the ced-1(e1735); ced-5(n1812) and ced-12(tp2);
ced-7(n1892) double mutants. In the first case in which pat-2 would
act in both pathways, we would expect that pat-2(st567) or pat-
2(RNAi) would not enhance the engulfment defect of the double
mutants. However, we found that the pat-2(st567) or pat-2(RNAi)
Figure 1. pat-2 and cdc-42 mutants are defective in apoptotic cell removal. (A) pat-2 loss of function does not affect the number of cell death
events. Embryonic cell deaths that occurred in the 200 min following the first cell death (up to about the 1.5-fold stage) were followed in wild-type
(white rhombi) and pat-2(st567) (black squares) embryos. The y axis shows the total number of cell death events at the different time points shown on
the x axis. The data shown are the average for two embryos for each genotype. The times corresponding to the comma and 1.5-fold stages are
indicated. (B–C) Cell corpses in pat-2(st567) (B) and cdc-42 (gk388) (C) mutants persist longer than in the wild-type. The persistence of cell corpses that
appeared 360–410 min after the first cleavage was recorded using four-dimensional Nomarski microscopy. The y axis shows the percentage of cell
corpses that persisted for the time indicated on the x axis. Forty corpses were analyzed for each genotype. The data of wild-type (white bars), pat-
2(st567) (gray bars); wild-type; Ex[Ppat-2pat-2Dcyto::gfp] (black bars) and pat-2(st567); Ex[Ppat-2pat-2Dcyto::gfp] (slashed bars) are shown in (B) and those
of the wild-type (white bars) and cdc-42(gk388) (gray bars) in (C).
doi:10.1371/journal.pgen.1002663.g001
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double mutants (Table 4). We therefore conclude that pat-2
probably functions in a pathway distinct from these two pathways
to promote the engulfment of cell corpses.
A recent study has shown that abi-1 (abl-1 interactor 1) acts in
parallel to the two major engulfment pathways during cell corpse
removal [57]. Our analysis showed that pat-2(RNAi) or pat-3(st564)
enhanced the engulfment defect in the abi-1(null) or abi-1(RNAi)
embryo (Table 4), showing that pat-2 and pat-3 function
independently of abi-1 to mediate the removal of apoptotic cells.
pat-2 functions in muscle cells to mediate the removal of
apoptotic cells
We next examined the localization of PAT-2 using the Ppat-2pat-
2::gfp or Ppat-2pat-2::mcherry transgene, which rescued the Ced and Pat
phenotypes of the pat-2 mutant (Table 3 and data not shown). PAT-
2::GFP or PAT-2::mCherry was found to be expressed in body wall
muscles and hypodermal cells during embryogenesis (Figure 2A, 2B
and Figure S2A). Notably, a strong GFP signal was observed along
the surface of apoptotic cells adjacent to muscle cells (Figure 2A and
2E), whereas a relatively weak GFP signal was seen around apoptotic
cellsengulfed byhypodermal cells(Figure2B and 2F). Our analysisof
embryos expressing the transgene Ppat-2nls::gfp, in which GFP was
expressed under the control of Ppat-2 and was predominantly localized
to the nucleus, indicated that Ppat-2 expression was absent from cell
corpses duringembryogenesis (Figure 2I, 2K, Figure S1 and Text S1).
Thus, the PAT-2::GFP signal surrounding apoptotic cells likely
originated from the surface of the engulfing cells. The localization of
PAT-2::GFP around the surface of apoptotic cells near body wall
muscles was not affected by the ced-1;ced-5 double mutation (Figure
S3),consistentwithourgeneticdatashowing thatpat-2acts in parallel
to ced-1 and ced-5 to mediate cell corpse engulfment. When PAT-
2::mCherry and PAT-3::GFP were co-expressed under the control of
their respective endogenous promoters, PAT-2::mCherry and PAT-
3::GFP were co-localized on apoptotic cells and to the dense bodies
(Z-disks) and M-lines of muscle cells (Figure S2A), in agreement with
t h ei d e at h a tP A T - 2a n dP A T - 3f o r mac o m p l e x .
In contrast to flies and mammals, C. elegans does not have
macrophage-like motile phagocytes; instead, apoptotic cells are
removed by their neighboring cells [36,38]. Hypodermal cells,
pharyngeal muscle cells, and intestinal cells have been shown to
function as engulfing cells [37,38]. Since pat-2 was expressed in both
hypodermal cells and body wall muscles, we tested whether it
functioned in muscle cells and/or hypodermal cells for the removal
of apoptotic cells. To this end, we expressed pat-2 cDNA under the
control of the Pajm-1 or Punc-54 promoter and examined the ability of
each transgene to rescue the Ced phenotype of the pat-2 mutant.
Pajm-1 is expressed in all epithelia including hypodermal cells [69],
whereas Punc-54 is expressed in body wall muscles [70]. We found
that expression of pat-2 by Punc-54, but not by Pajm-1, fully rescued the
Ced phenotype of the pat-2(st567) embryo (Table 2). Punc-54 did not
appear to express in apoptotic cells (Figure S4A). These results
support the notion that pat-2 acts in muscle cells to mediate cell
corpse removal during embryogenesis.
We next co-expressed PAT-2::mCherry and PAT-2::GFP by
the Ppat-2 and Punc-54 promoters, respectively, to monitor the PAT-
2-mediated and muscle-mediated engulfment processes simulta-
neously in the 1.5-fold embryos. Approximately 22.7% and 18.1%
of the cell corpses were enclosed by the PAT-2::mCherry and
PAT-2::GFP circles, respectively, and most of the mCherry and
GFP circles were co-localized, suggesting that most, if not all,
PAT-2-mediated engulfment involves muscle cells (Table S1).
CED-1 and INA-1 may function in the hypodermal cell-
mediated engulfment of apoptotic cells
CED-1 and INA-1/PAT-3 are engulfment receptors that are
expressed in multiple cell types, including hypodermis and body
Table 4. pat-2 promotes apoptotic cell engulfment in a
pathway distinct from previously known pathways.
Genotype No. of cell corpses
a
Comma 1.5-fold
ced-1(e1735) 19.161.7 24.161.4
ced-1(e1735); pat-2(RNAi) 23.762.3
** 29.164.6
**
ced-1(e1735); pat-2(st567)
b 23.063.2
** 28.161.8
**
ced-6(n1813) 19.362.1 20.362.2
ced-6(n1813); pat-2(RNAi) 25.361.5
** 25.561.8
**
ced-7(n1996) 21.161.4 24.261.7
ced-7(n1996); pat-2(RNAi) 28.861.6
** 30.662.0
**
ced-2(n1994) 18.462.1 22.863.6
ced-2(n1994); pat-2(RNAi) 23.161.4
** 25.662.4
**
ced-5(n1812) 30.362.7 35.362.1
ced-5(n1812); pat-2(RNAi) 33.162.3
** 42.963.3
**
pat-2(st567); ced-5(n1812)
c 35.663.1
** 40.662.8
**
ced-12(n3261) 21.862.4 25.662.7
ced-12(n3261); pat-2(RNAi) 28.961.9
** 32.163.1
**
ced-10(n1993) 23.961.6 25.362.3
ced-10(n1993); pat-2(RNAi) 30.461.5
** 30.661.2
**
ced-1(e1735); ced-5(n1812) 33.463.9 40.462.8
ced-1(e1735); ced-5(n1812); pat-2(RNAi) 45.962.4
## 48.462.2
##
ced-1(e1735); pat-2(st567); ced-5(n1812)
d 41.364.6
## 46.165.5
##
ced-12(tp2); ced-7(n1892) 33.264.1 40.564.5
ced-12(tp2); ced-7(n1892); pat-2(RNAi) 44.264.5
## 50.861.3
##
abi-1(ok640) 9.361.4 10.161.1
abi-1(RNAi) 10.060.9 10.060.6
abi-1(ok640); pat-2(RNAi) 15.061.8
** 14.562.1
*
abi-1(ok640); pat-3(RNAi) 14.861.1
** 14.161.2
*
abi-1(RNAi); pat-3(st564)
e 17.261.3
** 18.161.3
*
uig-1(ok884) 12.161.9 13.161.4
cdc-42(gk388)
f 11.961.6 13.061.1
uig-1(ok884); pat-2(RNAi) 12.261.5 13.160.9
cdc-42(gk388)
f; pat-2(RNAi) 13.061.3 13.062.4
aThe number of cell corpses in each genotype was scored at the indicated
embryonic stage.
bNon-transgenic progeny of ced-1(e1735); unc-79(e1068) pat-2(st567); Ex[Ppat-
2pat-2::gfp] mothers.
cNon-transgenic progeny of unc-79(e1068) pat-2(st567); ced-5(n1812); Ex[Ppat-
2pat-2::gfp] mothers.
dNon-transgenic progeny of ced-1(e1735); unc-79(e1068) pat-2(st567); ced-
5(n1812); Ex[Ppat-2pat-2::gfp] mothers.
eHomozygous progeny of pat-3(st564)/qC1 dpy-19(e1259) glp-1(q339)
heterozygous mothers.
fHomozygous progeny of cdc-42(gk388)/mIn1[mIs14 dpy-10(e128)] heterozygous
mothers. Double mutants were compared to the corresponding single mutants
(*p,0.05 and ** p,0.001), and triple mutants were compared to the
corresponding double mutants (
## p,0.001) at each stage. All comparisons
were performed using the unpaired t test. Data are presented as the mean 6
standard deviation (SD) for .15 embryos per stage.
doi:10.1371/journal.pgen.1002663.t004
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involving PAT-2 (Table 1 and Table 4). We therefore tested
whether CED-1 and INA-1 acted in specific cell types to mediate
the engulfment of apoptotic cells. Expression of ced-1 in
hypodermal cells using the Pajm-1 promoter fully rescued the ced-
1 engulfment defect, whereas expression of ced-1 in body wall
muscles using the Punc-54 promoter did not (Table 2). Similarly,
expression of ina-1 in hypodermal cells, but not muscle cells,
rescued the ina-1 engulfment defect (Table 2). These data suggest
that CED-1 and INA-1 preferentially act in hypodermal cells, at
least during the comma and 1.5-fold stages. This observation,
together with our result that PAT-2 predominantly functions in
muscle cells, indicates that different engulfing cells may utilize
different engulfment receptors to mediate cell corpse removal.
Removal of apoptotic MSpppaaa cells by muscle cells
requires PAT-2
The mesodermal MSpppaaa cell is generated in the head region
about 250 minutes after the first cleavage of a zygote [37]. After
circumferential migration to the dorsal midline, the MSpppaaa
Figure 2. PAT-2 is strongly expressed in muscle cells and clusters around apoptotic cells. (A–H) PAT-2::GFP, MOESIN::GFP, and GFP::CDC-
42 are localized to pseudopods around apoptotic cells. GFP (A–D) and DIC (E–H) images of wild-type embryos expressing PAT-2::GFP (A–B),
MOESIN::GFP (C), or GFP::CDC-42 (D) under the control of the indicated promoter. Apoptotic cells are indicated by arrows and shown enlarged in the
insets. The arrowheads indicate hypodermal cells. (I–K) Ppat-2nls::gfp is not expressed in apoptotic MSpppaaa cells. GFP (I), membrane-bound mRFP (J),
and DIC (K) images of an embryo co-expressing Punc-54ced-1::mrfp and Ppat-2nls::gfp. MSpppaaa cell corpses are indicated by the arrows and shown
enlarged in the insets. The arrowheads indicate the nucleus of the engulfing muscle cell. (L–M) The extracellular region of PAT-2 binds to the surface
of apoptotic cells. DIC (L) and PAT-2(ex)::mCherry (M) images of a ced-1(e1735); ced-5(n1812) double mutant embryo expressing PAT-2(ex)::mCherry
under the control of the heat-shock promoter. Apoptotic cells are indicated by arrows. (N–Q) GFP::CDC-42 and PAT-2::mCherry are co-localized to the
pseudopods around apoptotic MSpppaaa cells. DIC (N), GFP::CDC-42 (O), PAT-2::mCherry (P), and merged (Q) images of a wild-type embryo co-
expressing the transgenes Punc-54 gfp:cdc-42 and Ppat-2pat-2::mcherry. The MSpppaaa cells are indicated by arrows and shown in the insets. All scale
bars represent 5 mm.
doi:10.1371/journal.pgen.1002663.g002
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400 minutes after its generation, the MSpppaaa cell undergoes
apoptosis at the four-fold stage [37]. To examine whether the
apoptotic MSpppaaa cell was removed by a muscle cell, we
expressed membrane-bound monomeric red fluorescent protein
(mRFP) in muscle cells using Punc-54. MSpppaaa cell corpses were
found inside the adjacent muscle cells (Figure 2J and 2K), showing
that MSpppaaa cell corpses were engulfed by muscle cells. To
confirm this result, we tagged PAT-2 with mCherry and GFP and
co-expressed PAT-2::mCherry in body wall muscles using Punc-54
and PAT-2::GFP in hypodermal cells using Pajm-1 in wild-type
embryos. The PAT-2::mCherry, but not PAT-2::GFP, signal was
observed around apoptotic MSpppaaa cells (Figure S5), confirm-
ing that apoptotic MSpppaaa cells are engulfed by muscle cells,
but not hypodermal cells. The basement membrane between
muscle and hypodermis may limit the access of hypodermal cells to
the apoptotic MSpppaaa cell for engulfment.
We next examined whether the clearance of apoptotic
MSpppaaa cells is defective in pat-2 embryos by scoring apoptotic
MSpppaaa cells in wild-type and pat-2 embryos at specific
embryonic stages. The two stages during which the pharyngeal
grinder has just formed and the pharynx is pumping were chosen.
The MSpppaaa cell undergoes apoptosis during pharyngeal
grinder formation. Pharyngeal pumping begins about 1.5 hours
after grinder formation is complete. At the time when pharyngeal
grinder formation had just finished, only 19.6% of wild-type
embryos contained the MSpppaaa cell corpse and none remained
at the time when pharyngeal pumping occurred (Table 5).
However, 74.6% of pat-2 embryos contained the MSpppaaa cell
corpse at the time when pharyngeal grinder formation had just
finished, and 52.4% still contained a corpse when pharyngeal
pumping had started (Table 5). This shows that pat-2 is important
for the removal of apoptotic MSpppaaa cells. In addition, the
muscle-specific expression of pat-2 by Punc-54 significantly reduced
the percentage of pat-2 mutant embryos containing the MSpppaaa
cell corpse at the time when pharyngeal grinder formation had just
finished or pharyngeal pumping had started (Table 5). In contrast,
the hypodermal cell-specific expression of pat-2 by Pajm-1 failed to
do so (Table 5). These results show that pat-2 functions in muscle
cells to mediate the removal of the MSpppaaa cell corpse.
Three cells C1, C2 and C3, called as in reference [42], are
generated in the ventral side of embryos at approximately 300–
350 min after first cleavage and subsequently undergo apoptosis.
Their cell corpses are engulfed by the ventral hypodermal cells
ABplaapppp, ABpraapppa and ABplaapppa, respectively [42].
The duration time of these apoptotic cells appeared normal in the
pat-2 mutants (Table S2). This result further supports the notion
that pat-2 preferentially acts in muscle cells but not hypodermal
cells for cell-corpse removal. In contrast to pat-2, ced-1 has been
previously shown to be important for the hypodermal cell-
mediated removal of C1, C2 and C3 cell corpses [42]. In the
ced-1 mutants, the duration time of MSpppaaa cell corpses was
slightly longer than that of the wild-types: approximately 19% of
MSpppaaa cell corpses still persisted in the ced-1 mutants during
pharyngeal pumping, whereas none remained in the wild-type
embryos at this stage (Table 5). Thus, ced-1 also plays a minor role
in the muscle-mediated removal of apoptotic MSpppaaa cells in
late embryogenesis.
Muscle cell-mediated internalization of apoptotic cells is
defective in pat-2 mutants
The persistence of cell corpses in the pat-2 mutant could be due
to a defect in either the internalization or the degradation of the
corpse. We used the Punc-54myri::mrfp translational reporter to
express the MYRI::mRFP fusion protein on the surface of muscle
cells and followed the membrane processes of a muscle cell around
an apoptotic cell using the time-lapse fluorescence microscopy
analysis. The comma stage was chosen because the pat-2 embryos
at this stage show an increased number of cell corpses and the
embryos at this stage do not move around. In wild-type embryos,
MYRI::mRFP fusion protein appeared to localize to the growing
Table 5. pat-2 functions in the muscle-mediated clearance of apoptotic MSpppaaa cells.
Genotype Transgene % embryos with the MSpppaaa cell corpse (n)
a
% MSpppaaa cell corpses with mRFP
or GFP circle (n)
b
Grinder formation
c Pharyngeal pumping Grinder formation Pharyngeal pumping
Wild-type - 19.6 (56) 0 (33) N.D N.D
pat-2(st567)
d - 74.6 (63) 52.4 (84) N.D N.D
pat-2(st567) Ppat-2pat-2::gfp 21.4 (42) 0 (17) N.D N.D
pat-2(st567) Punc-54pat-2::gfp 16.7 (48) 0 (10) N.D N.D
pat-2(st567)
d Pajm-1pat-2::gfp 76.3 (38) 62.5 (16) N.D N.D
Wild-type Punc-54myri::mrfp 16.6 (18) 0 (17) 100 (18) 0 (17)
pat-2(st567)
d Punc-54myri::mrfp 76.1 (21) 47.8 (23) 0 (21) 0 (23)
cdc-42(gk388)
e Punc-54myri::mrfp 62.5 (24) 43.7 (16) 0 (24) 0 (16)
ced-1(e1735) Punc-54myri::mrfp 41.6 (22) 19.0 (21) 100 (20) 0 (21)
Wild-type Ppat-2pat-2Dcyto::gfp 39.1 (23) 43.3 (30) 66.6 (23) 53.8 (30).
pat-2(st567) Ppat-2pat-2Dcyto::gfp 69.2 (13) 61.5 (13) 0 (13) 0 (13)
aPercentage of embryos with the MSpppaaa cell corpse at the indicated developmental stage, with the number of embryos scored in parentheses.
bPercentage of MSpppaaa cell corpses labeled with the MYRI::mRFP or PAT-2Dcyto::GFPcircle at the indicated developmental stage, with the number of embryos scored
in parentheses.
cEmbryos at the stage when pharyngeal grinder formation had just finished were scored.
dHomozygous progeny of unc-79(e1068) pat-2(st567); Ex[Ppat-2pat-2::gfp] mothers.
eHomozygous progeny of the heterozygous cdc-42(gk388)/mIn1[mIs14 dpy-10(e128)] mothers. The transgenic worms were generated as described in Materials and
Methods.
doi:10.1371/journal.pgen.1002663.t005
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cell upon the completion of the internalization process (Figure 3A).
The MYRI::mRFP circle formed around an apoptotic cell in
approximately 6 minutes. However, in the pat-2(st567) mutant
embryos, the MYRI::mRFP circle formation took approximately
21 minutes to complete, more than three times longer than that in
the wild-type, indicating that the internalization process was
compromised.
We further examined the internalization of MSpppaaa cell
corpses in the pat-2 mutant using the Punc-54myri::mrfp transgene. As
shown in Table 5 and Figure 3B, in wild-type embryos, all
apoptotic MSpppaaa cells showed the MYRI::mRFP circle at the
time when grinder formation had just finished and their cell
corpses were cleared at the time of pharyngeal pumping.
However, in pat-2 mutants, no apoptotic MSpppaaa cells had
the MYRI::mRFP circle at the time when grinder formation had
just finished, and nearly half of MSpppaaa cell corpses still
persisted and showed no MYRI::mRFP circle at the time of
pharyngeal pumping (Table 5). These data indicate that pat-2 is
required for the internalization of an apoptotic MSpppaaa cell by
a muscle cell.
The extracellular domain of PAT-2 recognizes and binds
to apoptotic cells in vivo
We then examined whether PAT-2 recognized apoptotic cells to
trigger their internalization. To this end, we generated the
transgene Phsppat-2(ex)::mcherry, in which the coding sequence for
the PAT-2 extracellular domain with a signal sequence [PAT-
2(ex)] was fused to that of mCherry under the control of the heat-
shock promoter Phsp. The transgene was then introduced into the
wild-type and ced-1(e1735); ced-5(n1812) double mutant embryos.
The ced-1(e1735); ced-5(n1812) double mutant embryos contain
many persistent apoptotic cells, resulting in a greater chance of
seeing PAT-2(ex)::mCherry binding, especially during late em-
bryogenesis when very few cell corpses are present in the wild-type
embryos. We found that secreted PAT-2(ex)::mCherry clustered
on the surface of apoptotic cells (Figure 2M), albeit with a weaker
fluorescence intensity compared to that of PAT-2::GFP
(Figure 2A). Approximately 15.2% of apoptotic cells displayed
the PAT-2(ex)::mCherry circle in the ced-1(e1735); ced-5(n1812)
double mutant embryos at the 4-fold stage. A similar percentage
(16.6%) was observed in the wild-type embryos at the 1.5-fold
stage (Table S1). Thus, PAT-2(ex) recognizes and binds to the
surface of apoptotic cells. However, we do not know if binding is
direct or indirect.
We further examined whether PAT-2(ex)::mCherry bound to
specific apoptotic cells. Approximately 20% of the MSpppaaa cell
corpses had a PAT-2(ex)::mCherry circle (Table S1 and Figure
S6A), but none of C1, C2 and C3 cell corpses, which are engulfed
by hypodermal cells, had a PAT-2(ex)::mCherry circle (Table S1
and Figure S6C and S6D). This result indicates that PAT-2(ex)
binds to specific apoptotic cells and may explain why PAT-2 is
required for the removal of MSpppaaa (Table 5), but not C1, C2
or C3, cell corpses (Table S2) and why only a subset, but not all, of
apoptotic cells are labeled with PAT-2(ex)::mCherry (Figure 2L
and 2M). Furthermore, we used the Punc-54 promoter to express
PAT-2(ex)::mCherry and observed PAT-2(ex)::mCherry clustering
around apoptotic cells including the apoptotic MSpppaaa cell
(Figure S4B), despite the fact that the PAT-2(ex)::mCherry signal
was not as strong as that expressed by the Phsp promoter. This
result shows that PAT-2(ex)::mCherry expressed in and secreted
from muscle cells recognizes, and binds to, the surface of apoptotic
cells. Embryos with PAT-2(ex)::mCherry overexpression by either
Phsp or Punc-54 resulted in increased numbers of apoptotic cells at
the comma and 1.5-fold stages (Table 3) and delayed the removal
of MSpppaaa cell corpses (Figure S6A), indicating that PAT-
2(ex)::mCherry overexpression interferes with the normal process
of cell corpse engulfment.
The INA-1 extracellular domain, termed INA-1(N) as in
reference [46], has been shown to recognize apoptotic cells [46].
Figure 3. PAT-2 is required for the internalization of apoptotic cells. (A) The formation of MYRI::mRFP circles around cell corpses was
followed and time-lapse MYRI::mRFP images of wild-type and pat-2(st567) embryos expressing Punc-54myri::mrfp were shown. The time point
immediately prior to the appearance of trace amounts of MYRI::mRFP adjacent to cell corpses was set as 0 min. Apoptotic cells are indicated by
arrows and shown enlarged in the insets. (B) The DIC and MYRI::mRFP images of the apoptotic MSpppaaa cells in the wild-type and pat-2(st567)
embryos expressing Punc-54myri::mrfp. The MYRI::mRFP circle around the apoptotic MSpppaaa cell was observed in the wild-type but not pat-2(st567)
embryos. MSpppaaa cell corpses are indicated by arrows and shown in enlarged insets. Both scale bars represent 5 mm.
doi:10.1371/journal.pgen.1002663.g003
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apoptotic cells, we co-expressed PAT-2(ex)::mCherry and INA-
1(N)::GFP in embryos using the transgenes Phsppat-2(ex)::mcherry
and Phsp ina-1(N)::gfp. We found that PAT-2(ex)::mCherry was co-
localized with INA-1(N)::GFP on some apoptotic cells (Figure
S6E). Thus, the extracellular domains of PAT-2 and INA-1 can
recognize identical apoptotic cells, although they preferentially
function in different cell types for apoptotic cell removal.
The cytoplasmic domain of PAT-2 is required for cell-
corpse engulfment, but not for muscle assembly or
contraction
As shown above, PAT-2 binds to apoptotic cells and may serve
simply to tether the corpse to an engulfing cell or also initiate a
signaling pathway for engulfment. To distinguish between these
two possibilities, we tested whether the cytoplasmic domain of
PAT-2 was essential for signaling by deleting it and examining the
ability of truncated PAT-2Dcyto to rescue pat-2(st567) mutants.
We generated pat-2(st567); Ppat-2pat-2Dcyto::gfp transgenic animals
that expressed the PAT-2Dcyto::GFP fusion protein under the
control of the pat-2 promoter. To our surprise, PAT-2Dcyto::GFP
fully rescued the Pat phenotype of the pat-2(st567) mutant, but
failed to rescue the Ced phenotype (Table 3). The pat-2(st567); Ppat-
2pat-2Dcyto::gfp transgenic embryos contained increased numbers of
cell corpses (Table 3) at comma and 1.5-fold stages, and some of
the cell corpses persisted longer than those of the wild-type
embryos (Figure 1B), showing an engulfment defect. The non-Pat
phenotype of the transgenic embryos allowed us to count cell
corpses at and beyond the 2-fold stage, which is impossible for
homozygous pat-2(st567) embryos because of developmental
arrest. The pat-2(st567) embryos carrying the Ppat-2 pat-2Dcyto::gfp
transgene also had increased numbers of cell corpses at the 2-, 3-
and 4-fold stages (Table S3). Thus, pat-2 is required for the
engulfment of apoptotic cells throughout embryogenesis. In
addition, MSpppaaa cell corpses also persisted longer in the pat-
2(st567); Ppat-2 pat-2Dcyto::gfp transgenic embryos than those in
wild-type embryos. Approximately 61% of the MSpppaaa cell
corpses still persisted at the stage of pharyngeal pumping, while
none remained in the wild-type embryos at this stage (Table 5).
PAT-2Dcyto::GFP was localized to the surfaces, dense bodies
and M-lines of muscle cells in the wild-type and pat-2 mutants
(Figure S7), similar to PAT-2::GFP or PAT-2:: mCherry (Figure
S2, S7 and data not shown), suggesting that the cytoplasmic
domain is not required for PAT-2 localization. We then used the
PAT-2Dcyto::GFP signal to monitor the internalization of
MSpppaaa cell corpses by muscle cells. In the wild-type embryos,
approximately 66.6% of MSpppaaa cell corpses were enclosed by
the PAT-2Dcyto::GFP circle at the time when grinder formation
had just finished, whereas no MSpppaaa cell corpses were
enclosed by the PAT-2Dcyto::GFP circle in the pat-2(st567)
embryos at this stage (Table 5 and Figure S8). Thus, the
internalization of MSpppaaa cell corpses is defective in the pat-
2(st567); Ppat-2pat-2Dcyto::gfp embryos. This result and the afore-
mentioned data together indicate that the PAT-2 cytoplasmic
domain is required for the muscle-mediated engulfment of
apoptotic cells, but is dispensable for its subcellular localization
in muscle cells and function during muscle development.
Expression of the PAT-2Dcyto::GFP fusion protein in the wild-
type embryos resulted in increased numbers of cell corpses at the
comma and 1.5-fold stages comparable to those seen in pat-2
mutants, but failed to induce the Pat phenotype (Table 3). In
addition, PAT-2Dcyto::GFP also prolonged the duration time of
the MSpppaaa cell corpses and interfered with the internalization
of the MSpppaaa cell corpses (Table 5). For example, in the wild-
type embryos expressing PAT-2Dcyto::GFP, 39% of the
MSpppaaa cell corpses persisted at the time when grinder
formation had just finished, and 66.6% of these cell corpses were
internalized by engulfing muscle cells. However, in the control
wild-type embryos, only 16.6% of the MSpppaaa cell corpses were
present at this stage, and all the remaining cell corpses were
internalized by engulfing muscle cells (Table 5). This result
reinforces the specific function of the PAT-2 cytoplasmic domain
in the engulfment of apoptotic cells. PAT-2Dcyto::GFP may
compete with the endogenous PAT-2 for binding of PAT-3 or
apoptotic cells, but fail to initiate signaling for the internalization
of cell corpses.
PAT-2 functions through UIG-1 and CDC-42 to promote
the engulfment process
During the engulfment of apoptotic cells, cytoskeletal rear-
rangement occurs as an engulfing cell extends pseudopods around
an apoptotic cell [71]. Rho-family GTPases are important
regulators of the actin cytoskeleton [72]. Although CED-10
(RAC1) GTPase is required for cell corpse engulfment [55,72], our
data showing that a ced-10 mutation enhanced the engulfment
defect in the pat-2(RNAi) mutant (Table 4) and that ced-10
overexpression failed to rescue the engulfment defect of the pat-
2(RNAi) mutant (Table 6) suggest that pat-2 may act independently
of ced-10 in promoting the cytoskeletal rearrangement required for
the internalization process.
We then examined whether actin filament assembly occurred
during the muscle-mediated internalization of apoptotic cells.
MOESIN has been used in Drosophila and C. elegans to specifically
mark the filamentous form of actin [73,74]. Analysis of embryos
expressing Punc-54moesin::gfp in which MOESIN::GFP was ex-
pressed in muscle cells using Punc-54 showed a MOESIN::GFP
circle around apoptotic cells (Figure 2C), demonstrating that
filamentous actin assembly occurs as an engulfing muscle cell
extends pseudopods along the surface of an apoptotic cell.
A previous study showed that the Rho-family GTPase CDC-42
and UIG-1, a guanine nucleotide exchange factor (GEF) specific
for CDC-42, function downstream of PAT-2/PAT-3 signaling for
muscle assembly [75]. We next tested the involvement of uig-1 and
cdc-42 in PAT-2-mediated cell corpse engulfment. The cdc-
42(gk388) allele has a deletion that eliminates part of the 59
regulatory sequence, the entire first exon, and part of the first
intron of the cdc-42 gene (C. elegans Gene Knockout Consortium),
while the uig-1(ok884) mutation deletes the region coding for the
DH/PH domain, which has the GEF activity [76]. Both alleles are
likely to be null. We found that uig-1 or cdc-42 embryos contained
increased numbers of cell corpses at the comma and 1.5-fold stages
(Table 4), similar to those observed in the pat-2 mutants. A four-
dimensional DIC analysis of cell corpse persistence in the cdc-
42(gk388) embryos revealed a cell-corpse engulfment defect. In the
wild-type, 97% of cell corpses disappeared within 40 minutes and
none lasted longer than 60 minutes (Figure 1C). However, in the
cdc-42(gk388) mutants, only 40% of the cell corpses disappeared
within 40 minutes and almost 40% persisted longer than
60 minutes (Figure 1C).
We next tested whether cdc-42 acted in the same pathway as pat-
2 to promote apoptotic cell engulfment. We found that neither cdc-
42 nor uig-1 increased the number of cell corpses in pat-2 mutants
at the comma and 1.5-fold stages (Table 4), suggesting that cdc-42
and uig-1 both act in the same genetic pathway as pat-2. Like PAT-
2::GFP, the GFP::CDC-42 fusion protein expressed using the
transgene Punc-54gfp::cdc-42 was localized in muscle pseudopods
around apoptotic cells (Figure 2D). In addition, the transgene Punc-
54gfp::cdc-42 rescued the engulfment defect of the cdc-42(gk388)
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in hypodermal cells, did not (Table 6). This result suggests that cdc-
42 acts in muscle cells to mediate the engulfment of apoptotic cells.
This muscle-specific function of cdc-42 is further supported by the
observation that loss of cdc-42 results in a defect in the engulfment
of apoptotic MSpppaaa cells (Table 5), but not C1, C2 or C3 cells
(Table S2). When Punc-54gfp::cdc-42 and Ppat-2pat-2::mcherry were co-
expressed, GFP::CDC-42 was co-localized with PAT-2::mCherry
along the surface of apoptotic MSpppaaa cells (Figure 2N–2Q).
Furthermore, the Punc-54gfp::cdc-42 transgene rescued the engulf-
ment defect of the pat-2(RNAi) embryos (Table 6). These results
support the model that cdc-42 functions downstream of pat-2 in the
muscle-mediated engulfment of apoptotic cells.
CED-10 and CDC-42 are not exchangeable in function
during cell-corpse engulfment
Our genetic data suggested that cdc-42 acts with pat-2 in the
same pathway, whereas ced-10 functions in a partially redundant
manner with pat-2 to mediate cell corpse engulfment (Table 4). We
then tested whether the functions of ced-10 and cdc-42 in
engulfment were exchangeable when ubiquitously overexpressed.
We found that overexpression of ced-10 or constitutively active ced-
10 V12 by the heat-shock promoter Phsp, which rescued the ced-
10(n1993) or ced-10(tm597) mutant ([50], Table 6), failed to rescue
the engulfment defect of the pat-2(RNAi) embryos (Table 6).
Reciprocally, overexpression of cdc-42 by Phsp, which rescued the
pat-2 mutant (Table 6), did not rescue the engulfment defect of the
ced-10(n3246) mutants (Table 6). Moreover, overexpression of cdc-
42 by the Phsp or Pajm-1 promoter also failed to rescue the defective
engulfment of the ced-1(e1735) or ina-1(gm144) mutants, respec-
tively (Table 6). These data suggest that the mechanisms by which
cdc-42 and ced-10 mediate the actin-based cytoskeletal rearrange-
ment during cell-corpse engulfment are distinct and that their
functions are not exchangeable.
INA-1 and PAT-2 can partially substitute for each other in
cell-corpse engulfment
As shown in Figure S6E, the INA-1 and PAT-2 extracellular
domains can recognize the same apoptotic cells. We found that
overexpression of pat-2 by the Pajm-1 promoter in hypodermal cells
partially rescued the defective engulfment of the ina-1 mutants
and, reciprocally, overexpression of ina-1 by the Punc-54 promoter
in muscle cells also partially rescued the engulfment defect of the
pat-2 mutants (Table 2). This result indicates that ina-1 and pat-2
can partially substitute for each other in cell corpse engulfment.
Interestingly, overexpression of ina-1 by the Punc-54 promoter,
which partially rescued the engulfment defect of the pat-2 mutants,
did not rescue that of the cdc-42(gk388) mutants (Table 6) suggests
that cdc-42 may be necessary for ina-1 overexpression-induced
engulfment in muscle cells. If so, ina-1 overexpression in muscle
cells may promiscuously activate cdc-42 signaling, which, in turn,
leads to the engulfment of apoptotic cells. Nevertheless, ina-1
overexpression does not efficiently activate the phagocytosis
machinery for cell corpse removal in muscle cells since only
partial rescue of the pat-2 engulfment defect by ina-1 overexpres-
sion was observed. Similarly, overexpression of pat-2 dose not
efficiently induce the phagocytosis machinery in hypodermal cells.
This may, in part, explain why pat-2 and ina-1 preferentially
function in different cell types for cell corpse removal, despite that
they are expressed in both cell types.
In contrast, overexpression of ced-1 under the control of the Punc-
54 promoter failed to rescue the defective engulfment of the pat-2
mutants (Table 2). In a reciprocal experiment, overexpression of
pat-2 by the Pajm-1 promoter also failed to rescue the defective
engulfment of the ced-1 mutants (Table 2). These results indicate
that ced-1 and pat-2 functions are distinct and not exchangeable in
cell corpse engulfment.
Discussion
The engulfment of apoptotic cells requires the recognition and
subsequent internalization of apoptotic cells by the engulfing cells.
Here, we showed that, in C. elegans, the integrin a subunit PAT-2
functions in both the recognition and internalization steps. pat-2
loss of function resulted in an increased number of embryonic cell
corpses due to a defect in cell corpse removal. Our data showed
that PAT-2 bound to apoptotic cells through its extracellular
domain and initiated downstream signaling via its cytoplasmic
domain. We characterized the pat-2 signaling pathway and
identified a previously unassigned function of cdc-42 and uig-1 in
cell corpse engulfment. We further showed that PAT-2 predom-
inantly functioned in muscle cells to mediate the engulfment
process. We propose that binding of PAT-2 to an apoptotic cell
results in the recruitment of UIG-1 and the subsequent activation
Table 6. cdc-42 acts downstream of pat-2 during cell-corpse
engulfment.
Genotype Transgene Heat-shock No. of cell corpses
a
Comma 1.5-fold
Wild-type - 2 9.061.1 9.961.3
Wild-type Punc-54gfp::cdc-42 2 9.362.5 9.661.2
cdc-42(gk388)
b Punc-54gfp::cdc-42 2 9.261.5
** 9.361.1
**
cdc-42(gk388)
b Pajm-1gfp::cdc-42 2 12.460.9 13.361.2
cdc-42(gk388)
b Punc-54ina-1::gfp 2 12.061.3 13.660.5
pat-2(RNAi) - 2 12.961.7 13.261.6
pat-2(RNAi) - + 13.361.5 13.262.0
pat-2(RNAi) Punc-54gfp::cdc-42 2 9.361.6
** 10.161.4
**
pat-2(RNAi) Phspgfp::cdc-42 + 9.561.1
** 10.661.7
**
pat-2(RNAi) Phspced-10 + 13.261.7 13.461.6
pat-2(st567)
c Phspced-10V12 + 13.961.5 13.861.3
ina-1(gm144) - 2 12.261.6 12.561.9
ina-1(gm144) Pajm-1gfp::cdc-42 2 12.361.0
d 12.460.9
d
ced-10(n3246) - 2 23.762.0 29.862.0
ced-10(n3246) - + 23.662.4 29.663.3
ced-10(n3246) Phspgfp::cdc-42 + 23.962.2 29.862.4
ced-10(tm597) - 2 30.263.1 38.463.6
ced-10(tm597) Phspced-10V12 + 11.562.7
** 12.162.2
**
ced-1(e1735) 2 19.161.7 24.161.4
ced-1(e1735) Phspgfp::cdc-42 + 18.561.1 23.861.9
aThe number of cell corpses in each genotype was scored at the indicated
embryonic stage.
bHomozygous progeny of the heterozygous cdc-42(gk388)/mIn1[mIs14 dpy-
10(e128)] mothers.
cHomozygous progeny of the heterozygous unc-79(e1068) pat-2(st567)/dpy-
17(e164) mothers.
dThe number of cell corpses was scored in the F1 transgenic progeny of the
injected worms, n=10 at each stage. Mutants carrying the transgene were
compared to mutants without the transgene (*p,0.05 and ** p,0.001). The
transgenic worms were generated as described in Materials and Methods.
Statistical analysis was performed using the unpaired t test. The data are
presented as the mean 6 standard deviation (SD), n.15 (unless noted above).
doi:10.1371/journal.pgen.1002663.t006
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rearrangement as a muscle cell extends pseudopods around an
apoptotic cell.
ThefindingthattruncatedPAT-2lackingthecytoplasmicdomain
(PAT-2Dcyto::GFP ) fully rescued the Pat phenotype of the pat-2
mutants, but failed to rescue the engulfment defect (Table 3) argues
against the possibility that the engulfment defect of the pat-2 mutant
is a secondary effect caused by abnormality of muscle assembly or
organization during embryogenesis. PAT-2 is co-localized with
PAT-3 to the dense bodies and M-lines (Figure S2A), which are
platforms serving as anchoring sites for signaling/adapter proteins in
muscle attachment and organization [65]. Because the deletion of
the cytoplasmic domain of PAT-2 affects neither its localization
pattern (Figure S7) nor its function in muscle development (Table 3),
muscle development probably requires only the transmembrane and
extracellulardomains,whicharelikelysufficientfortheinteractionof
PAT-2 with PAT-3 and/or the extracellular matrix. Thus, the PAT-
2/PAT-3 integrin likely mediates the intracellular signaling and/or
adaptor protein binding through the cytoplasmic domain of PAT-3,
but not that of PAT-2, for muscle development. In contrast, the
requirement of the cytoplasmic domain of PAT-2 for cell-corpse
removal suggests that this domain is important for signaling and/or
serves as an anchorage site for adapter proteins during cell-corpse
internalization.
The pat-2(st567) mutants show a weak engulfment phenotype
compared with that of the ced-1 mutants during embryogenesis
(Table 2). One possible explanation for the weak engulfment
defect is that pat-2 predominantly functions in muscle cells, while
only a small fraction of cell corpses (e.g. ,20% of cell corpses in
the 1.5-fold stage embryos, as shown in Table S1) are removed by
muscle cells. Secondly, other engulfment receptor(s) may act
redundantly with pat-2 in muscle-mediated engulfment. For
instance, both PAT-2 and CED-1 are involved in the muscle-
mediated internalization of MSpppaaa cells, despite that PAT-2
plays a bigger role than CED-1 (Table 5).
The PAT-2 extracellular region bound to apoptotic cells when
PAT-2(ex) was fused to mCherry and overexpressed using the heat
shock promoter (Figure 2M). Because exposed PS is detected on
the surface of apoptotic MSpppaaa cells (Figure S1B), which are
then removed by the PAT-2-mediated engulfment process
(Table 5), PAT-2 might recognize exposed PS on apoptotic
MSpppaaa cells. Mammalian integrins avb3 and avb5 have been
shown to bind to apoptotic cells via the secreted bridging molecule
MFG-E8 [25,48]. In addition, integrin avb3 binds synergistically
with the cell-surface protein CD36 to apoptotic cells through the
bridging molecule thrombospondin, an extracellular matrix
glycoprotein [50]. MFG-E8 binds to integrin av through its
RGD domain. On the basis of amino acid sequence, PAT-2 is
more closely related to the RGD-binding integrins than to the
laminin-binding integrins. However, C. elegans does not appear to
have an MFG-E8 homolog. A screen for RGD-containing
molecules may be helpful in testing the involvement of RGD-
containing molecules in the binding of PAT-2(ex)::mCherry to
apoptotic cells.
Like PAT-2, CED-1 and INA-1 are expressed in muscle and
hypodermal cells [40,46]. It is intriguing that different receptors
are preferentially used in different cell types when they are all
present in these cells. This may be, in part, because some receptors
preferentially bind to a subset, but not all, apoptotic cells. For
example, PAT-2(ex)::mCherry binds to MSpppaaa, but not C1,
C2 or C3, cell corpses (Figure S6A, S6C and S6D) and PAT-2 is
required for the removal of MSpppaaa, but not C1, C2 or C3, cell
corpses. In contrast, INA-1 and CED-1 receptors recognize
apoptotic C1, C2 and C3 cells and mediate the engulfment of
these cells [42,46]. However, some cell corpses can be recognized
by multiple receptors. For example, PAT-2(ex)::mCherry and
INA-1(N)::GFP are co-localized on some apoptotic cells (Figure
S6E). Therefore, additional factor(s) other than the receptor-cell
corpse interaction determines the cell-type specificity of engulf-
ment receptors. The observation that CDC-42 preferentially
functions in muscle cells but not hypodermal cells for engulfment
suggests that the downstream molecule(s) are important for the
cell-type specificity of engulfment receptors. CED-10 and CDC-42
are important for the actin-based cytoskeleton rearrangement
[72], which occurs during engulfment of apoptotic cells ([55],
Figure 2C). Hypodermal cells and muscle cells appear to have
different requirement for CED-10 and CDC-42 in cell corpse
removal, although the two GTP ases are expressed in both cell
types [76]. Hypodermal cells and muscle cells may utilize different
actin-based phagocytosis mechanisms or employ different ways to
activate the phagocytosis machinery for cell corpse removal.
We showed that the muscle-mediated internalization of cell
corpses took apporximately 6 mintues (Figure 3A). Similarly, the
internalization of the C3 cell corpse by the hypodermal cell
ABplaapppp took about 6 minutes [42,46]. However, previous
studies by Wang et al. and Zou et al. [43,53] showed that the time
for the CED-1::GFP-mediated internalization of apoptotic cells
may take about 18 or 25 minutes, respectively, although the
identities of the engulfing cells are unclear. Therefore, the time
necessary for the entire internalization process to occur from
initiation to completion appears different for different engulfing
cells. Nonetheless, at least some engulfment processes mediated
by the muscle cell and hypodermal cell proceeds with similar
kinetics.
Recently, conditional deletion of integrin av in the mouse
immune system revealed that this protein is essential for the
engulfment of apoptotic cells by gut-associated macrophages and
dendritic cells [4]. In addition, mice lacking MFG-E8, which
mediates apoptotic cell clearance through integrin av,a r e
defective in the removal of apoptotic B cells by tingible body
macrophages in the spleen germinal centers [77]. However, little
was previously known about whether integrin a or other
engulfment receptors were involved in apoptotic cell removal
mediated by amateur phagocytes, such as muscle cells. C. elegans
provides a good system for studying the amateur phagocyte-
mediated engulfment of apoptotic cells, as it does not have
professional phagocytes. Our data showed that PAT-2 acts in
muscle cells and transduces the engulfment signal through a novel
signaling pathway for apoptotic cell removal. Recently, a mouse
lacking ELMO1 showed a defect in Sertoli cell-mediated
engulfment of apoptotic germ cells, but no engulfment defect
was detected in macrophages or fibroblasts [31]. This result,
together with our data, suggest that, like professional phagocytes
[78], amateur phagocytes in different tissues utilize different sets
of engulfment receptors and signaling molecules for apoptotic cell
engulfment at the whole organism level.
Materials and Methods
Strains and alleles
The N2 Bristol strain was used as the reference wild-type strain.
All strains were maintained on nematode growth medium (NGM)
plates with Escherichia coli OP50 as the food source at 20uC unless
otherwise noted [79]. The following mutations were used: linkage
group I (LGI), ced-1(e1735), ced-12 (n3261, tp2); LGII, cdc-
42(gk388), mIn1[mIs14 dpy-10(e128)]; LGIII, abi-1(ok640), ced-
4(n1162), ced-6(n1813), ced-7(n1892, n1996), unc-79(e1068), pat-
2(st567), dpy-17(e164), pat-3(st564), qC1 dpy-19(e1259) glp-1(q339);
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n3246, tm597); LGIV, uig-1(ok884). dpy-17(e164) was used to
balance unc-79(e1068) pat-2(st567). The homozygous unc-79(e1068)
pat-2(st567) mutants were also maintained using the extrachro-
mosomal Ppat-2pat-2::gfp or Ppat-2pat-2::mcherry transgene. In either of
the transgenic lines, the unc-79(e1068) pat-2(st567) mutant embryos
that lost the transgene were both Pat and Ced. The numbers of
cell corpses in the unc-79(e1068) mutant at the comma and 1.5-fold
stages were similar to those of the wild-type at the same stage,
indicating that unc-79(e1068) does not affect apoptosis. qC1 dpy-
19(e1259) glp-1(q339) was used to balance pat-3(st564). mIn1 was
used to balance cdc-42(gk388). The pat-2(st567) allele has a G441D
alternation in the extracellular domain. The information of the
transgenic strains used in this work is listed in Table S4.
Plasmid construction
Three vectors were used to generate constructs expressing
fluorescent proteins, the gfp vector pPD95.75, the mcherry vector
pYW806, and the mrfp vector pYW897. pYW806 and pYW897
were respectively generated by replacing gfp in pPD95.75 with
mcherry or mrfp via the KpnI/EcoRI sites. To generate Ppat-2pat-2::gfp
(pYW903) or Ppat-2pat-2::mCherry (pYW950), the 10 kb fragment
containing the 4 kb upstream sequence and the full-length pat-2
coding region without the stop codon was PCR-amplified from the
cosmid F54F2 (Sanger Institute, Cambridge, United Kingdom)
using the primers TCCCCCCGGGTTTATGACTCACAGAC
and GGGTACCGATGCATTTGTC CGTGACGT, and cloned
into pPD95.75 or pYW806, respectively, via the KpnI site. The
full-length pat-2 cDNA construct (pYW901) was generated by
inserting into yk616b4 (Dr. Yuji Kohara) via the PstI site a 0.6 kb
pat-2 cDNA which was amplified by RT-PCR using the primers
AACTGCAGATGCGAGAGGGTAGTTTTCC and GATTC-
TTCTTTCCTGGAACTGCAGC. To generate Ppat-2nls::gfp
(pYW949) or Ppat-2gfp (pYW903), the 4 kb upstream sequence of
pat-2 was first amplified by PCR from the cosmid F54F2 using the
primers TCCCCCCGGGTTTATGACTCACAGAC and
TCCCCCCGGGATCTACTGG AAATTTG and inserted into
pPD95.67 or pPD95.75, respectively. The Punc-54gfp (pYW899) or
Punc-54mcherry (pYW900) construct was generated by inserting the
1k bHindIII/KpnI fragment of pPD30.38 containing Punc-54 into
pPD95.75 or pYW806, respectively. The Pajm-1gfp (pYW902) was
generated by inserting into pPD95.75 via the SalI/BamHI sites a
5.5 kb Pajm-1 fragment which was amplified by PCR from pBR980
[69] using the primers CGTCGACCGATTTGACCGTTCGA-
TAAG and CGGATCCTCGTCGGTA GTACTCGTCC. Pced-
1gfp (pYW898) was generated by inserting into pPD95.75 via the
SphI site a 5 kb Pced-1 fragment which was PCR-amplified from
genomic DNA using the primers GGCATGCATACCTCCTGA-
TATG GGGTGA and GCATGCTTGC GGCTGCAAAAAAA-
CAGGG. Pced-1ced-1::gfp (pYW904) was generated by three-piece
ligation. The 6 kb PCR-amplified fragment from Pced-1ced-1::gfp
[40] using the primers AGGTACCATGCGTCTCATTCTCC-
TTGTGC and GGTCGA CGTGATTGTTCAGATGA and the
2.4 kb fragment PCR-amplified from genomic DNA using the
primers CGTCGACCTCTATTAGAAGAGCATGACG and
TGGTACCGAGGTGTACAAATTGTCCTGAGC were insert-
ed into pYW898 via the SalI and KpnI sites. Pced-1ced-1::gfp fully
rescued the engulfment defect of the ced-1(e1735) mutant (data not
shown). To generate pYW901 containing pat-2 cDNA without the
stop codon, pat-2 cDNA was PCR-amplified from the full-length
pat-2 cDNA clone using the primers CGGTACCATGCGA-
GAGGGTAGTTTTCC and GGGTACCGATAGCATTTGTC
CGTGACGT and inserted into the pGEM-T Easy vector
(Promega) via the KpnI site. To generate Punc-54pat-2::gfp
(pYW913) or Punc-54pat-2::mCherry (pYW916), the 3.7 kb KpnI pat-
2 fragment from pYW901 was inserted into pYW899 or pYW900,
respectively, via the KpnI site. To generate Punc-54ced-1::gfp
(pYW905), the 8.5 kb KpnI ced-1 fragment from pYW904 was
inserted into pYW899 via the KpnI site. To generate Punc-54 ced-
1::mrfp (pYW941), a 8.6 kb SpeI/BamHI fragment, containing Punc-
54 and the first 4.9 Kb of ced-1, and a 3.6 kb BamHI/KpnI
fragment, corresponding to the rest ced-1 sequence, of pYW905
were fused to a 1.5 kb KpnI/SpeI fragment, containing the mrfp
sequence, of pYW897 by three-piece-ligation. To generate Punc-
54moesin::gfp (pYW940), the 0.6 kb SmaI/NcoI fragment containing
the moesin actin-binding sequence was inserted into pYW899 via the
NheI/NcoI sites. The moesin plasmid was a gift from Dr. Fabio Piano
[75]. To generate Punc-54 gfp::cdc-42 (pYW906), two plasmids
gfp_Ntag_TA and cdc-42_Ntag_TA were generated first. To
generate the gfp_Ntag_TA plasmid, PCR-amplified gfp, using
oligonucleotides CGGTACCATGAGTAAAGGAG AAGAACT
and GTCTAGATTTGTATAGTTCATCCATGCC as primers
and pPD95.75 as template was inserted to the vector pGEM T-
Easy. To generate the cdc-42_Ntag_TA plasmid, PCR-amplified
cdc-42 from k1101h01(Y. Kohara) using primers GTCTAGAATG-
CAGACGATCAAGTGCG and CGTTAACCTAGAGAA-
TATTGCACTTCTTC was inserted into the pGEM T-Easy
vector. The 1 kb HindIII/KpnI fragment of pPD30.38 containing
Punc-54,t h eKpnI/ XbaI gfp fragment from the gfp_Ntag_TA
plasmid, and the XbaI/EcoR1 cdc-42 fragment from the cdc-
42_Ntag_TA plasmid were inserted to the pPD95.75 vector
previously digested with HindIII and EcoRI in a four-piece-ligation
reaction to generate pYW906. To generate Pajm-1pat-2::gfp
(pYW948) or Pajm-1ced-1::gfp (pYW914), the 3.7 kb KpnI pat-2
sequence from pYW901 or the 8.5 kb KpnI ced-1 sequence from
pYW904 was inserted, respectively, into pYW902. To generate Pced-
1pat-2::gfp (pYW942), the 3.7 kb KpnI pat-2 sequence from pYW901
was inserted into pYW898 via the KpnI site. To generate Ppat-2pat-
2Dcyto::gfp (pYW964), pat-2Dcyto was PCR-amplified from pYW901
using the primers CGGTACCATGCGA GAGGGTAGTTTTCC
and TTGGT ACCGTC CTATAGAATAATGCAA and cloned
into pYW903 via the KpnI site. To generate Punc-54pat-2(ex)::
mcherry(pYW917),the DNAfragmentcorrespondingtopat-2(ex)was
PCR-amplified from pYW901 using the primers CGGTAC-
CATGCGAGAGG GTAGTTTTCC and CGGTACCA-
GATCTCTTCC TTCTTCAGA and cloned into pYW900 via
the KpnI site. To generate Phsppat-2(ex)::mcherry (pYW966), the 4.2 kb
NheI/PvuI fragment of the Punc-54 pat-2(ex)::mCherry plasmid contain-
ing pat-2(ex)::mCherry was inserted into pPD49.78 via the NheI/PvuI
sites. To generate Phspgfp::cdc-42 (pYW959), the 1.5 kb KpnI/HpaI
fragment of pYW906 corresponding to gfp::cdc-42 was inserted into
pPD49.78 and pPD49.83 (different tissue specificity) via the KpnI/
EcoRV sites. To generate the Punc-54ina-1::gfp plasmid, Punc-54 was
PCR-amplified using pYW913 as template and oligonucleotides
GCATCCGCCAAGCTTGTCTTCTTC and GGATCCG-
GTACCGT CGACGCTAC as primers and used to replace the
Pced-1 region of Pced-1ina-1::gfp via the SphI/BamHI sites. To generate
the Ppat-3pat-3::gfp (pYW1091) plasmid, the 10.2 kb pat-3 genomic
DNA was amplified by PCR and subsequently cloned into the
pPD95.75 vector via the XmaI/KpnI sites. To generate the Punc-
54myri::mrfp (pYW1092) construct, the myri::mrfp cDNA of Punc-
86myri::gfp (from C. Bargmann) was inserted into the Punc-54mrfp
vector via the KpnI site. To generate the Pajm-1gfp::cdc-42 (pYW1093)
plasmid, the gfp region of the pPD95.75 plasmid was replaced by
gfp::cdc-42 from the Phspgfp::cdc-42 construct via the KpnI site, and the
resulting construct was then digested with BamHI and SalIa n d
subsequently inserted with the BamHI and SalI fragment containing
the Pajm-1 promoter from pYW902.
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To generate thepat-2 RNAi clone, the 1.3 kb PstI/HindIII fragment
of pat-2 cDNA was inserted into the pPD129.36 vector. The pat-3
RNAi plasmid was obtained from the J. Ahringer RNAi library. All
RNAi experiments were carried out using a bacterial feeding protocol
[80]. In brief, L4 larvae were laid out on control plates (pPD129.36) or
the indicated RNAi plates and cultured at 20uC for 48 h, then the F1
embryos were picked for phenotypic analysis.
Transgenic animals
Transgenic animals were generated by microinjection of the
indicated plasmid(s) (3–50 ng/mL), using the pRF4[rol-6 (su1006)],
pTG96[sur-5::gfp]o rPsur-5rfp plasmids (50 ng/mL) as coinjection
markers [81,82]. The injection procedure was performed as
described previously [8]. The resulting transgenes and genetic
backgrounds of the strains were listed in Table S4. Phspced-10V12
was injected with the coinjection marker pTG96[sur-5::gfp]t ounc-
79(e1068) pat-2(st567)/dpy-17(e164), and no rescue of the Pat
phenotype was observed. To score cell corpses, transgenic
embryos carrying the transgene Phspced-10V12 and pTG96[sur-
5::gfp] were scored and only the data for those which later
exhibited the Pat phenotype were used.
Microscopy
Embryos were mounted on a 4% agar pad in M9 buffer in the
presence (four-fold stage embryos) or absence (comma and 1.5-fold
stage embryos) of 30 mM sodium azide at 20uC. Cell corpses were
analyzed using DIC microscopy, as previously described [46]. A
Zeiss Axioplan 2 microscope equipped with a digital camera
(AxioCam; Carl Zeiss, Inc.) and 4.7 AxioVision imaging software
was used. To obtain the cell corpse data of homozygous pat-
2(st567) embryos derived from the heterozygous unc-79(e1068) pat-
2(st567)/dpy-17(e164) mothers, embryos at the indicated develop-
mental stages were analyzed and only the data for those which
later exhibited the Pat phenotype were used. To obtain the cell
corpse data of homozygous pat-2(st567) embryos derived from unc-
79(e1068) pat-2(st567) mothers carrying either Ppat-2pat-2::gfp or
Ppat-2pat-2::mcherry transgene, non-fluorescent embryos at the
indicated developmental stages were analyzed. To obtain the cell
corpse data of homozygous cdc-42(gk388) embryos derived from
the heterozygous cdc-42(gk388)/mIn1[mIs14 dpy-10(e128)] mothers,
GFP-negative embryos at the indicated developmental stages were
analyzed. To analyze cell death events during embryogenesis,
wild-type or mutant embryos were filmed during the period 200–
460 min after the first cleavage and the time point at which each
cell corpse appeared was noted and was reported relative to the
first cell death for comparison between the wild-type and mutants.
About 40–50 serial Z-sections were recorded at 0.4 mm intervals
every 1 min. To measure the duration of cell corpses in the wild-
type and mutants, cell corpses appearing between 360 to 410 min
after the first cleavage during embryogenesis were followed, and
about 50–60 serial Z-sections were recorded at 0.3 or 0.4 mm
intervals every 1 min. To monitor the muscle-mediated internal-
ization of apoptotic cells, the fluorescence images of wild-type or
mutant embryos carrying the Punc-54myri::mrfp transgene were
recorded using the DeltaVision microscope (GE Healthcare
company) equipped with a digital camera (Photometrics Cascade
II 512 EMCCD) at 1 (for wild-type) or 3 (for mutant)-minute
intervals for about 120 minutes.
Heat shock experiments
For the heat shock rescue experiments, transgenic embryos were
subjected to heat shock at 33uC for 30 min and transferred to
20uC to recover for 2 hours, then cell corpses in embryos at the
indicated stages were counted. To test the binding of PAT-
2(ex)::mCherry to apoptotic cells and its effect on cell-corpse
engulfment when overexpressed, embryos carrying the transgene
Phsppat-2(ex)::mcherry or embryos carrying the transgenes Phsppat-
2(ex)::mcherry and Phspina-1(N)::gfp were subjected to heat shock at
33uC for 60 min and transferred to 20uC to recover for 4–5 hours,
then embryos were examined using fluorescence microscopy (for
mCherry and/or INA-1(N)::GFP signal) or DIC microscopy (for
cell corpses). To overexpress GFP::CDC-42, CED-10V12 or
Annexin V::mRFP by heat-shock, the embryos carrying the
respective transgene were subjected to heat shock at 33uC for
30 min and transferred to 20uC to recover for 2 hours, then
embryos were examined using fluorescence microscopy (mCherry
signal) or DIC microscopy (cell corpses).
Supporting Information
Figure S1 pat-2 expression is not detectable in embryonic
apoptotic cells. (A) GFP, Annexin V::mRFP, merged GFP and
mRFP, and DIC images of a wild-type early embryo co-expressing
Ppat-2nls::gfp and Phspannexin V::mrfp transgenes after heat shock
treatment. Annexin V::mRFP, which is secreted and clusters
around the surface of apoptotic cells, was used to label apoptotic
cells. Apoptotic cells are indicated by arrows. The scale bar
represents 5 mm. (B) GFP, Annexin V::mRFP, merged GFP and
mRFP, and DIC images of a wild-type late embryo co-expressing
Ppat-2nls::gfp and Phspannexin V::mrfp transgenes after heat shock
treatment. Apoptotic MSpppaaa cells are indicated by arrows.
The scale bar represents 5 mm.
(TIF)
Figure S2 PAT-2 and PAT-3 are co-localized in muscle cells
and apoptotic cells. A wild-type larva (A) and an embryo (B) co-
expressing the transgenes Ppat-2pat-2::mcherry and Ppat-3pat-3::gfp. (A)
PAT-2::mCherry and PAT-3::GFP were co-localized to the dense
bodies (arrows) and M-lines (arrowheads) in muscle cells. The scale
bar represents 10 mm. (B) PAT-2::mCherry and PAT-3::GFP were
co-localized around an apoptotic cell (arrows). The scale bar
represents 5 mm.
(TIF)
Figure S3 PAT-2::GFP localization around cell corpses is not
disrupted by either ced-1 or ced-5 mutation. PAT-2::GFP (left) and
DIC (right) images of a ced-1(e1735); ced-5(n1812) embryo carrying
the transgene Ppat-2pat-2::gfp. Apoptotic cells are indicated by
arrows and shown enlarged in insets. The scale bar represents
5 mm.
(PDF)
Figure S4 Expression of Punc-54nls::gfp or Punc-54pat-2(ex)::mcherry
transgene in embryos. (A) DIC and GFP images of a ced-1(e1735)
mutant embryo expressing Punc-54nls::gfp. Arrows indicate apoptotic
cells. (B) DIC and PAT-2(ex)::mCherry images of a wild-type
embryo expressing Punc-54pat-2(ex)::mcherry. Arrows indicate
MSpppaaa cells. Both scale bars represent 5 mm.
(TIF)
Figure S5 The MSpppaaa cell corpse is engulfed by a muscle
cell. PAT-2::GFP, PAT-2::mCherry, and DIC images of an
embryo co-expressing Pajm-1pat-2::gfp and Punc-54pat-2::mcherry.
MSpppaaa cell corpses are indicated by arrows and shown
enlarged in insets. The scale bar represents 5 mm.
(TIF)
Figure S6 Localization of PAT-2 (ex)::mCherry, CED-1::GFP
and INA-1(N)::GFP around apoptotic cells. (A) Localization of
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PLoS Genetics | www.plosgenetics.org 13 May 2012 | Volume 8 | Issue 5 | e1002663PAT-2 (ex)::mCherry around the apoptotic MSpppaaa cell. DIC
and PAT-2 (ex)::mCherry images of a wild-type embryo expressing
Phsppat-2(ex)::mcherry at the time of pharyngeal pumping. Apoptotic
MSpppaaa cells are indicated by arrows. (B) Localization of CED-
1::GFP around the apoptotic MSpppaaa cell. DIC and CED-
1::GFP images of a wild-type embryo expressing Pced-1ced-1::gfp. (C,
D) The PAT-2(ex)::mCherry signal is not observed around C1, C2
and C3 cell corpses. DIC and PAT-2 (ex)::mCherry images of ced-
1(e1735); ced-5(n1812) double mutant embryos expressing the
transgene Phsppat-2(ex)::mcherry. C1, C2 and C3 cell corpses are
indicated by arrows. (E) Co-localization of PAT-2 (ex)::mCherry
and INA-1(N)::GFP on some apoptotic cells. DIC, PAT-2
(ex)::mCherry, INA-1(N)::GFP and merged images of a ced-
1(e1735); ced-5(n1812) double mutant embryo co-expressing the
transgenes Phsppat-2(ex)::mcherry and Phspina-1(N)::gfp. Apoptotic cells
are indicated by arrows. All scale bars represent 5 mm.
(TIF)
Figure S7 Deletion of the cytoplasmic domain of PAT-2 does
not affect its localization to muscle cell surfaces, dense bodies and
M-lines. (A) The DIC and PAT-2Dcyto::GFP images of wild-type
and pat-2(st567) adult worms expressing the transgene Ppat-2pat-
2Dcyto::gfp. PAT-2Dcyto::GFP is localized to muscle cell boundar-
ies (indicated by open arrowheads, outlined in the right panel),
dense bodies (indicated by arrows) and M-lines (indicated by close
arrowheads). The scale bar represents 10 mm. (B–C) PAT-2::GFP
and PAT-2Dcyto::GFP are localized to the surface of muscle
precursor cells. The DIC, PAT-2Dcyto::GFP (B) and PAT-2::GFP
(C) images of wild-type and pat-2(st567) embryos carrying the Punc-
54pat-2Dcyto::gfp transgene (B) or the wild-type carrying the Ppat-
2pat-2::gfp transgene (C). All scale bars represent 5 mm.
(TIF)
Figure S8 The internalization of MSpppaaa cell corpses is
defective in the pat-2(st567); Ex[Ppat-2pat-2Dcyto::gfp] embryos. The
DIC and PAT-2Dcyto::GFP images of a wild-type and a pat-
2(st567) embryos expressing Ppat-2pat-2Dcyto::gfp at the stage when
grinder formation had finished. A PAT-2Dcyto::GFP circle was
detected around the MSpppaaa cell corpse (indicated by an arrow)
in the wild-type (A) but not in the pat-2(st567) (B) embryo. The
engulfing muscle cell for the MSpppaaa cell corpse is indicated by
an arrowhead. The scale bar represents 5 mm.
(PDF)
Table S1 Localization of PAT-2 or PAT-2(ex) around apoptotic
cells.
(DOC)
Table S2 The engulfment of C1, C2 and C3 cell corpses appears
normal in pat-2 and cdc-42 mutant embryos.
(DOC)
Table S3 Effects of pat-2Dcyto::gfp on the Ced phenotype during
mid and late embryogenesis.
(DOC)
Table S4 List of transgenic strains and transgenes used in this
work.
(DOC)
Text S1 pat-2 does not appear to be expressed in embryonic
apoptotic cells.
(RTF)
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